drugset / Trial / NCT05006417
Botox for the Treatment of Recurrent Chronic Exertional Compartment Syndrome
NaSingle-groupOpen-labelTreatment
Summary
10 participants with Recurrent Chronic Exertional Compartment Syndrome (R-CECS) will be enrolled in a 6 month study at the University of Wisconsin Hospitals and Clinics to test the hypothesis that injection of Botox into the affected muscle group will alleviate pain associated with R-CECS.
Timeline
- Start
- 2022-11-23
- Primary completion
- 2022-11-23
- Completion
- 2022-11-23
Outcome
Outcome not reported
Stopped (Business): “issues with supplier of strength testing equipment, presumed to go out of business”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | — | — |